Doximity, Inc.

NYSE:DOCS Rapporto sulle azioni

Cap. di mercato: US$8.0b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Doximity Crescita futura

Future criteri di controllo 1/6

Doximity prevede che gli utili e i ricavi cresceranno rispettivamente di 5.7% e 7.8% all'anno. Si prevede che l'EPS crescerà di 8.9% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 19.9% in 3 anni.

Informazioni chiave

5.7%

Tasso di crescita degli utili

9.0%

Tasso di crescita dell'EPS

Healthcare Services crescita degli utili31.1%
Tasso di crescita dei ricavi7.8%
Rendimento futuro del capitale proprio19.9%
Copertura analitica

Good

Ultimo aggiornamento19 Sep 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

Sep 23
Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Aug 18
There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Aug 10
Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Doximity Faces Slower Revenue Growth As R&D Costs May Rise

Jul 23

Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

Jul 23
Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Jul 01
At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Jun 09
Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

May 04
Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Apr 16
With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Mar 26
Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Feb 15
We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Feb 13
What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Jan 04
Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Dec 14
Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 30
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Sep 25
Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Jul 29
A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Jul 09
Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

The Returns At Doximity (NYSE:DOCS) Aren't Growing

Jun 21
The Returns At Doximity (NYSE:DOCS) Aren't Growing

Doximity: Digital Health Play With Strong Fundamentals

Jun 21

A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Apr 07
A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Mar 20
Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Doximity: Good Business But Extremely Overvalued

Feb 18

Doximity Q3 Earnings: Disappointing Results

Feb 10

Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Dec 25
Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: On The Right Path To Further Consolidate Market Share

Dec 22

Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Dec 04
Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Doximity up 16% after fiscal 2023 Q2 beats, FY revenue range includes consensus

Nov 10

Doximity, down 9%, falls below IPO price

Oct 12

Previsioni di crescita degli utili e dei ricavi

NYSE:DOCS - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/202761218724025010
3/31/202656316123023417
3/31/202551914720321217
6/30/2024494161162168N/A
3/31/2024475148178184N/A
12/31/2023468138162167N/A
9/30/2023448123160165N/A
6/30/2023437119186192N/A
3/31/2023419113173180N/A
12/31/2022402119173180N/A
9/30/2022384141151159N/A
6/30/2022362148131138N/A
3/31/2022344133121127N/A
12/31/2021317107113117N/A
9/30/202127757110114N/A
6/30/202124330103107N/A
3/31/2021207227883N/A
12/31/2020177144853N/A
3/31/2020116112226N/A
3/31/20198611415N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di DOCS ( 5.7% all'anno) è superiore al tasso di risparmio ( 2.5% ).

Guadagni vs Mercato: Si prevede che gli utili di DOCS ( 5.7% all'anno) cresceranno più lentamente rispetto al mercato US ( 15.1% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di DOCS cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di DOCS ( 7.8% all'anno) crescerà più lentamente rispetto al mercato US ( 8.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di DOCS ( 7.8% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di DOCS sarà basso tra 3 anni ( 19.9 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y